Impact of new oral anti-coagulant agents on in-vivo platelet aggregation in patients with non-valvular atrial fibrillation: Xa inhibitor vs. direct thrombin inhibitor
Demographic and clinical characteristics associated with initiation of individual oral anticoagulants among patients with newly diagnosed venous thromboembolism